Kim, D.; Tiseo, M.; Ahn, M.; Reckamp, K.; Hansen, K. Holmskov; Kim, S.; Huber, R.; West, H.; Groen, H.; Hochmair, M.; Leighl, N.; Gettinger, S.; Langer, C.; Paz-Ares Rodriguez, L.; Smit, E.; Reichmann, W.; Kerstein, D.; Haluska, F. und Camidge, D.
(2016):
Brigatinib (BRG) in Crizotinib (CRZ)-Refractory ALK plus Non-Small Cell Lung Cancer (NSCLC): efficacy and safety results from ALTA, a pivotal randomized phase 2 Trial.
In: Annals of Oncology, Vol. 27: iv4-
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0923-7534 |
| Language: | English |
| Item ID: | 46475 |
| Date Deposited: | 27. Apr 2018 08:11 |
| Last Modified: | 04. Nov 2020 13:23 |
Actions (login required)
- View Item
